Medviso

VISO Clinical sprl is dedicated to support Clinical Research Organizations (CROs), Laboratories, Biotechs and Pharmaceutical companies in innovative aspects related to preclinical and clinical research activities. VISO Clinical supports disruptive approaches and initiatives in new technologies and processes of clinical trials > Blockchain in Clinical Trials is one of the most recent areas that VISO Clinical is supporting. Blockchain network offers a disruptive way to put patients at the center of clinical research by letting them own their health data, re-create trust in clinical trials, reduce costly and opaque process by which quality health data is currently collected by pharmaceutical companies to monitor safety & efficacy of investigational drugs. Blockchain is considered by many clinical trials stake-holders as a unique opportunity to set a new standard of transparency and engagement in its relationship with patients and regulators, via real-time monitoring of the effects of drugs, and compensating patients for their active involvement in clinical research. VISO Clinical supports the Clinical Trials Community in this new approach by providing combined expertises in Blockchain and Clinical Trials. Its helps CROs, Bio & Pharma companies to develop their understanding and strategies in this new model through a consultative and comprehensive approach.